Prof Mike Rogers

Mike Rogers relocated to Sydney in 2012 and heads the Bone Therapeutics Lab at the Garvan Institute of Medical Research. He is also a conjoint Professor at St Vincent’s Clinical School at UNSW Australia. He graduated with a degree in Biochemistry in 1989 and a PhD in bone pharmacology in 1994 from the University of Sheffield, UK. He moved to the University of Aberdeen, Scotland in 1997, where he led the Musculoskeletal Research Programme, recognised as a EULAR Centre of Excellence. He was twice the first recipient of prestigious young investigator awards - the ECTS Iain T. Boyle Award and the IBMS Herbert Fleisch Award - in recognition of his breakthrough research that identified the molecular mechanisms of action of bisphosphonate drugs used to treat metabolic bone diseases. Mike’s interests now focus on immune regulation of bone metastasis and pharmacological interventions, as well as autoinflammatory diseases involving the mevalonate-cholesterol pathway.

Supported By